Vaccines and Immunologics

It seems we can't find what you're looking for.

Sep2025

A Major Milestone in the Fight Against Drug-Resistant Tuberculosis: The Department of Health approved the Inclusion of Pretomanid in the Philippine National Drug Formulary

As the world prepares to commemorate World Tuberculosis (TB) Day, Faberco Life Sciences Incorporated proudly announces a breakthrough in the

Aug2025

Scaling Up Early Detection: Mylan HIV Self-Test Kit Now Recommended for Government Financing

Faberco Life Sciences Inc. (FLSI) played a pivotal role in the registration and Health Technology Assessment (HTA) approval of the

Aug2025

BREAKING BARRIERS IN HIV TESTING: A PARTNERSHIP THAT EMPOWERS

We are proud to announce a powerful partnership between Faberco Life Sciences Inc., KonsultaMD, and Southstar Drug, a game-changing step

Jul2025

A Major Milestone in the Fight Against Drug-Resistant Tuberculosis: HTA Council Recommends Pretomanid for Possible Financing

As the world prepares to observe World Tuberculosis (TB) Day, Faberco Life Sciences Incorporated is proud to share a significant

Jun2025

Faberco Life Sciences Celebrates Pride Month: Advocating for Awareness, Inclusion, and Responsible HIV Self-Testing

Faberco Life Sciences Inc. (FLSI) proudly joined the LGBTQIA+ community in celebrating the beginning of Pride Month through our participation

May2025

Healthier Tomorrows: Ending TB with a Smart Combination

The most recent World Health Organization (WHO) report reveals a concerning resurgence of tuberculosis, now ranking as a leading infectious

Apr2025

Faberco Life Sciences Inc at the 62nd PPS Annual Convention 2025

The 62nd PPS Annual Convention held from April 6 to 9, 2025, under the theme: Next-Gen Pediatrics: Bridging Science, Practice

Oct2024

Faberco Life Sciences at the 2nd PPATH Annual Convention 2024

Faberco Life Sciences Inc. participated in the 2nd Philippine Professional Association for Transgender Health (PPATH) Annual Convention 2024. This premier